Diagnostics (Dec 2021)

Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

  • Diego Santos García,
  • Lucía Naya Ríos,
  • Teresa de Deus Fonticoba,
  • Carlos Cores Bartolomé,
  • Lucía García Roca,
  • Maria Feal Painceiras,
  • Cristina Martínez Miró,
  • Hector Canfield,
  • Silvia Jesús,
  • Miquel Aguilar,
  • Pau Pastor,
  • Marina Cosgaya,
  • Juan García Caldentey,
  • Nuria Caballol,
  • Inés Legarda,
  • Jorge Hernández Vara,
  • Iria Cabo,
  • Lydia López Manzanares,
  • Isabel González Aramburu,
  • María A. Ávila Rivera,
  • Víctor Gómez Mayordomo,
  • Víctor Nogueira,
  • Víctor Puente,
  • Julio Dotor,
  • Carmen Borrué,
  • Berta Solano Vila,
  • María Álvarez Sauco,
  • Lydia Vela,
  • Sonia Escalante,
  • Esther Cubo,
  • Francisco Carrillo Padilla,
  • Juan C. Martínez Castrillo,
  • Pilar Sánchez Alonso,
  • Maria G. Alonso Losada,
  • Nuria López Ariztegui,
  • Itziar Gastón,
  • Jaime Kulisevsky,
  • Marta Blázquez Estrada,
  • Manuel Seijo,
  • Javier Rúiz Martínez,
  • Caridad Valero,
  • Mónica Kurtis,
  • Oriol de Fábregues,
  • Jessica González Ardura,
  • Ruben Alonso Redondo,
  • Carlos Ordás,
  • Luis M. López Díaz,
  • Darrian McAfee,
  • Pablo Martinez-Martin,
  • Pablo Mir

DOI
https://doi.org/10.3390/diagnostics11122380
Journal volume & issue
Vol. 11, no. 12
p. 2380

Abstract

Read online

Background and objective: Diplopia is relatively common in Parkinson’s disease (PD) but is still understudied. Our aim was to analyze the frequency of diplopia in PD patients from a multicenter Spanish cohort, to compare the frequency with a control group, and to identify factors associated with it. Patients and Methods: PD patients who were recruited from January 2016 to November 2017 (baseline visit; V0) and evaluated again at a 2-year ± 30 days follow-up (V2) from 35 centers of Spain from the COPPADIS cohort were included in this longitudinal prospective study. The patients and controls were classified as “with diplopia” or “without diplopia” according to item 15 of the Non-Motor Symptoms Scale (NMSS) at V0, V1 (1-year ± 15 days), and V2 for the patients and at V0 and V2 for the controls. Results: The frequency of diplopia in the PD patients was 13.6% (94/691) at V0 (1.9% in controls [4/206]; p p p = 0.006), a higher score on the NMSS at V0 (OR = 1.009; 95%CI, 1.012–1.024; p = 0.015), and a greater increase from V0 to V2 on the Unified Parkinson’s Disease Rating Scale–III (OR = 1.039; 95%CI, 1.023–1.083; p p = 0.049) scores were independent factors associated with diplopia (R2 = 0.25; Hosmer and Lemeshow test, p = 0.716). Conclusions: Diplopia represents a frequent symptom in PD patients and is associated with motor and non-motor severity.

Keywords